These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2418715)

  • 1. [Experimental pharmacology of atracurium dibesylate].
    Meistelman C; Lienhart A
    Ann Fr Anesth Reanim; 1985; 4(6):461-4. PubMed ID: 2418715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacology of atracurium: a new competitive neuromuscular blocking agent.
    Hughes R; Chapple DJ
    Br J Anaesth; 1981 Jan; 53(1):31-44. PubMed ID: 6161627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of the dose-response curve for atracurium dibesylate in the anesthetized adult].
    Lienhart A; Meistelman C; Maurel C; Deriaz H; Nebout T; Viars P
    Ann Fr Anesth Reanim; 1985; 4(6):471-6. PubMed ID: 2936285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans.
    Rupp SM; McChristian JW; Miller RD
    Anesthesiology; 1985 Jul; 63(1):16-9. PubMed ID: 3160265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats.
    Wastila WB; Maehr RB; Turner GL; Hill DA; Savarese JJ
    Anesthesiology; 1996 Jul; 85(1):169-77. PubMed ID: 8694363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium].
    Savarese JJ; Lien CA; Belmont MR; Wastila WB
    Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the neuromuscular blocking properties and side-effects of the two new isoquinolinium bisquaternary compounds (BW.252C64 and BW.403C65).
    Hughes R
    Br J Anaesth; 1972 Jan; 44(1):27-42. PubMed ID: 4109994
    [No Abstract]   [Full Text] [Related]  

  • 8. The cerebral effects of pancuronium and atracurium in halothane-anesthetized dogs.
    Lanier WL; Milde JH; Michenfelder JD
    Anesthesiology; 1985 Dec; 63(6):589-97. PubMed ID: 2932982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effects of atracurium in man].
    Guggiari M; Gallais S; Bianchi A; Guillaume A; Viars P
    Ann Fr Anesth Reanim; 1985; 4(6):484-8. PubMed ID: 2418716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia.
    Foldes FF; Nagashima H; Boros M; Tassonyi E; Fitzal S; Agoston S
    Br J Anaesth; 1983; 55 Suppl 1():97S-103S. PubMed ID: 6190489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of atracurium besylate (BW 33A): a new non-depolarizing muscle relaxant.
    Basta SJ; Ali HH; Savarese JJ; Sunder N; Gionfriddo M; Cloutier G; Lineberry C; Cato AE
    Anesth Analg; 1982 Sep; 61(9):723-9. PubMed ID: 6213181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethonium.
    McCoy EP; Mirakhur RK
    Acta Anaesthesiol Scand; 1995 Aug; 39(6):744-7. PubMed ID: 7484027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fumarates: unique nondepolarizing neuromuscular blocking agents that are antagonized by cysteine.
    Lien CA; Savard P; Belmont M; Sunaga H; Savarese JJ
    J Crit Care; 2009 Mar; 24(1):50-7. PubMed ID: 19272539
    [No Abstract]   [Full Text] [Related]  

  • 16. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histamine plasma concentration and cardiovascular effects of non-depolarizing muscle relaxants: comparison of atracurium, vecuronium, pancuronium and pipecuronium in coronary surgical patients at risk].
    Brinkmann M; Günnicker M; Freund U; Schieffer M; Peters J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jun; 33(6):362-6. PubMed ID: 9689393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atracurium, vecuronium, pancuronium and tubocurarine on renal sympathetic nerve activity in baroreceptor denervated dogs.
    Yoneda I; Goto H; Nishizawa M; Unruh GK; Arakawa K
    Br J Anaesth; 1994 Jun; 72(6):679-82. PubMed ID: 8024916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cumulative properties of three new nondepolarizing neuromuscular blocking drugs BW A444U, atracurium and vecuronium.
    Ali HH; Savarese JJ; Basta SJ; Sunder N; Gionfriddo M
    Br J Anaesth; 1983; 55 Suppl 1():107S-111S. PubMed ID: 6134539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and clinical evaluation of neuromuscular blocking agents.
    Hughes R
    J Pharmacol Methods; 1984 Aug; 12(1):1-27. PubMed ID: 6100317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.